Renaissance Technologies - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$6,730
+591.7%
100,200
+610.6%
0.01%
+1000.0%
Q2 2023$973
-51.1%
14,100
-65.9%
0.00%
-66.7%
Q1 2023$1,991
+29.0%
41,300
+33.7%
0.00%
+50.0%
Q4 2022$1,543
-99.9%
30,900
-56.0%
0.00%
-50.0%
Q3 2022$2,864,000
-56.5%
70,200
-61.2%
0.00%
-50.0%
Q1 2022$6,581,000
+163.7%
181,100
+197.9%
0.01%
+166.7%
Q2 2021$2,496,00060,8000.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2022
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders